Live Science on MSN1d
Why does dairy make antibiotics less effective?
But did you know that dairy products can make some drugs less effective? This effect is particularly problematic for certain ...
Ozempic Butt Isn't The Strangest Side Effect Of The Drug. Here's What Else To Expect.
Taking Ozempic can cause nausea, diarrhea, vomiting, and potential muscle loss. Here, doctors share common and uncommon side ...
BioSpace10d
GSK Settles Zantac Lawsuits for $2.2B, Analysts Now Shift Focus to Vaccines
The settlement, which is at the low end of Jefferies analysts’ $2 billion to $3.5 billion estimate, will resolve 93% of the ...
Drugmaker to settle nearly 80K Zantac lawsuits for up to $2.2 billion
UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level ...
MoneyWeek10d
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer ...
GSK Shares Climb on $2.2 Billion Zantac Lawsuit Settlement — Update
GSK shares top the Stoxx Europe 600 index on Thursday after the pharmaceutical company agreed to pay up to $2.2 billion to settle thousands of U.S. lawsuits over claims its discontinued heartburn ...
GSK Stock Jumps as UK Drug Giant Resolves Most US Zantac Lawsuits
GSK shares in London jumped 5% Thursday after the British drug giant said it has resolved most of the U.S. lawsuits it faced ...
Pharma company GSK agrees to pay $2.3bn in US settlements on lawsuits over Zantac cancer claims
However the pharmaceutical giant said it "has not admitted any liability" by settling the case as "the scientific consensus ...
Ealing Times10d
GSK shares jump after landmark £1.68bn heartburn drug settlement
Shares in drugmaker GSK surged on Thursday after it struck a 2.2 billion US dollar (£1.68 billion) settlement to resolve tens of thousands of lawsuits in the US over its discontinued heartburn drug ...
GSK shares jump on $2.2 billion Zantac settlement
GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits ...
GSK settles vast majority of Zantac claims for $2.2 billion
The settlement will see GSK resolve around 80,000 of the Zantac claims it faces for sums well below the $30 billion worst-case scenario figure currently priced into GSK's share price, Shore Capital ...